Xueting Ou

940 citations
11 papers · 234 indexed · h-index 4
Topics
Hepatitis B Virus Studies (5 papers)Antifungal resistance and susceptibility (4 papers)Fungal Infections and Studies (4 papers)
Partner nations
ChinaCanadaUnited States

In The Last Decade

Xueting Ou

10 papers receiving 233 citations

Peers

Xueting Ou
Comparison fields: 5 of 47
  • Epidemiology 158
  • Infectious Diseases 146
  • Oncology 35
  • Molecular Biology 33
  • Toxicology 16
Replace Ya-Ling Huang with:
Ya-Ling Huang Taiwan
Xiaofan Lu China
Espérance Mukawera Canada
Shireen Khan United States
Hanna Erdmann Germany
Beniamino Schiavone Italy
Bingtai Lu China
Xuetao Wang China
Carlos Antônio do Nascimento Santos Brazil
Ambra Pastori Italy
Xueting Ou relative to Ya-Ling Huang Taiwan Ya-Ling Huang's profile →
Citations per field
00.5×2.7×
Ya-Ling Huang · 1×
Citations per year

Countries citing papers authored by Xueting Ou

Since Specialization
Citations

This map shows the geographic impact of Xueting Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueting Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueting Ou more than expected).

Fields of papers citing papers by Xueting Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueting Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueting Ou. The network helps show where Xueting Ou may publish in the future.

Co-authorship network of co-authors of Xueting Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Xueting Ou. A scholar is included among the top collaborators of Xueting Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueting Ou. Xueting Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 1
6 9
7 65
8 45
9 107
10
[Factors associated with mortality in cryptococcal meningitis].
2
11
[Evaluation of low-dose amphotericin B and flucytosine in the treatment of cryptococcal meningitis].
2

About Xueting Ou

Xueting Ou is a scholar working on Hepatology, Toxicology and Epidemiology, having authored 11 papers that have together received 234 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (5 papers), Antifungal resistance and susceptibility (4 papers) and Fungal Infections and Studies (4 papers). The work is most often cited by research in Infectious Diseases (146 citations), Toxicology (16 citations) and Epidemiology (158 citations). Xueting Ou has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Jiqin Wu, Xinhua Weng, Bin Xu, Liping Zhu, Qiangqiang Zhang, Yawen Xu, Chunxiao Liu, Bingkun Li, Hulin Li and Yiming Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports and American Journal of Tropical Medicine and Hygiene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026